PLSE RSI Chart
Last 7 days
4.6%
Last 30 days
4.3%
Last 90 days
-15.1%
Trailing 12 Months
7.6%
Historical Charts for Stock Metrics
Year | Q1 | Q2 | Q3 | Q4 |
---|---|---|---|---|
2024 | 0 | 0 | 0 | 0 |
2023 | 0 | 0 | 0 | 0 |
2022 | 1.9M | 2.1M | 1.6M | 700.0K |
2021 | 0 | 0 | 682.0K | 1.4M |
2020 | 0 | 607.0K | 326.0K | 0 |
2019 | 0 | 0 | 0 | 0 |
Datesorted ascending | Name | Buy/Sell | $ Value | Avg. Price | # Shares | Title |
---|---|---|---|---|---|---|
Dec 12, 2023 | duggan robert w | bought | 164,691 | 9.15 | 17,999 | - |
Dec 11, 2023 | duggan robert w | bought | 843,504 | 9.36 | 90,118 | - |
Dec 08, 2023 | duggan robert w | bought | 1,112,900 | 9.54 | 116,656 | - |
Dec 07, 2023 | duggan robert w | bought | 687,890 | 9.19 | 74,852 | - |
Dec 06, 2023 | duggan robert w | acquired | 59,101 | 5.95 | 9,933 | - |
Dec 06, 2023 | duggan robert w | bought | 750,286 | 9.06 | 82,813 | - |
Dec 05, 2023 | duggan robert w | bought | 616,636 | 9.34 | 66,021 | - |
Dec 04, 2023 | duggan robert w | acquired | 430,099 | 10.66 | 40,347 | - |
Dec 04, 2023 | duggan robert w | bought | 280,260 | 10.38 | 27,000 | - |
Dec 01, 2023 | duggan robert w | bought | 413,592 | 9.07 | 45,600 | - |
Which funds bought or sold PLSE recently?
View All DetailsDatesorted ascending | Fund Name | Type | % Chg | $ Change | $ Held | % Portfolio |
---|---|---|---|---|---|---|
May 16, 2024 | JANE STREET GROUP, LLC | reduced | -17.41 | -169,448 | 241,546 | -% |
May 16, 2024 | CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | reduced | -38.9 | -18,389 | 14,145 | -% |
May 15, 2024 | OSTERWEIS CAPITAL MANAGEMENT INC | unchanged | - | -3,530 | 8,710 | -% |
May 15, 2024 | DEUTSCHE BANK AG\ | reduced | -3.77 | -29,707 | 64,541 | -% |
May 15, 2024 | STATE STREET CORP | added | 12.99 | -742,290 | 3,046,240 | -% |
May 15, 2024 | MORGAN STANLEY | reduced | -18.61 | -234,032 | 322,130 | -% |
May 15, 2024 | PRICE T ROWE ASSOCIATES INC /MD/ | new | - | 88,000 | 88,000 | -% |
May 15, 2024 | BANK OF AMERICA CORP /DE/ | reduced | -2.72 | -3,018,520 | 6,789,900 | -% |
May 15, 2024 | BARCLAYS PLC | reduced | -48.94 | -172,000 | 99,000 | -% |
May 15, 2024 | LM Advisors LLC | sold off | -100 | -29,743 | - | -% |
Unveiling Pulse Biosciences Inc's Major ShareHolders
Date Filed | Name of Filer | Percent of Class | No. of Shares | Form Type | |
---|---|---|---|---|---|
Peers (Alternatives to Pulse Biosciences Inc)
Name | Mkt Capsorted ascending | Revenue | Price %, 1M | Returns, 1Y | P/E | P/S | Rev 1-Yr | Inc 1-Yr |
---|---|---|---|---|---|---|---|---|
LARGE-CAP | ||||||||
ABT | 181.0B | 40.3B | 32.18 | 4.49 | ||||
BDX | 68.3B | 19.7B | 51.24 | 3.46 | ||||
ALGN | 20.4B | 3.9B | 44.2 | 5.22 | ||||
BAX | 18.0B | 14.9B | 6.79 | 1.21 | ||||
MID-CAP | ||||||||
ATR | 9.8B | 3.5B | 31.27 | 2.76 | ||||
HSIC | 9.6B | 12.5B | 24.63 | 0.77 | ||||
BIO | 8.4B | 2.6B | -26.02 | 3.22 | ||||
XRAY | 5.9B | 3.9B | -62.84 | 1.49 | ||||
AXNX | 3.4B | 387.1M | -216.3 | 8.9 | ||||
PDCO | 2.3B | 6.6B | 11.93 | 0.35 | ||||
SMALL-CAP | ||||||||
AHCO | 1.3B | 3.2B | -1.91 | 0.41 | ||||
ANIK | 376.6M | 169.3M | -4.9 | 2.23 | ||||
ANGO | 241.9M | 324.0M | -1.26 | 0.75 | ||||
APYX | 56.1M | 50.5M | -2.46 | 1.11 | ||||
AEMD | 1.0M | 3.7M | -0.09 | 0.28 |
Pulse Biosciences Inc News
Income Statement (Quarterly) | |||||||||||||||
Description | (%) Q/Q | 2024Q1 | 2023Q4 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q3 | 2019Q2 |
Revenue | - | - | - | - | - | - | 265,000 | 444,000 | 844,000 | 574,000 | 9,000 | 21,000 | 78,000 | 218,000 | 290,000 |
Cost Of Revenue | - | - | - | - | 1,291,000 | 8,400,000 | 1,344,000 | 909,000 | - | 727,000 | - | - | - | - | - |
Costs and Expenses | -15.3% | 10,615,000 | 12,533,000 | 9,562,000 | 8,736,000 | 18,025,000 | 14,279,000 | 17,717,000 | 16,254,000 | 14,847,000 | 12,905,000 | - | - | - | - |
Operating Expenses | - | - | - | - | - | - | - | - | - | - | 12,905,000 | 11,354,000 | 11,950,000 | 11,964,000 | 11,649,000 |
S&GA Expenses | -100.0% | - | 4,734,000 | 3,733,000 | 2,582,000 | 3,088,000 | 3,787,000 | 4,498,000 | 5,301,000 | 4,256,000 | 4,191,000 | 3,999,000 | 4,074,000 | 5,606,000 | 5,146,000 |
R&D Expenses | -13.6% | 6,741,000 | 7,799,000 | 5,829,000 | 4,095,000 | 4,517,000 | 5,458,000 | 6,769,000 | 5,658,000 | 6,460,000 | 6,968,000 | 5,870,000 | 6,181,000 | 6,192,000 | 6,337,000 |
EBITDA Margin | -0.8% | -60.93 | -60.45 | -72.85 | -83.49 | -40.98 | -29.97 | -34.07 | -44.05 | -73.36 | - | - | - | - | - |
Interest Expenses | - | - | - | - | - | - | - | - | - | - | 9,000 | 21,000 | 78,000 | 218,000 | 290,000 |
Income Taxes | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Earnings Before Taxes | 15.1% | -10,137,000 | -11,933,000 | -9,801,000 | -9,197,000 | -18,039,000 | -13,996,000 | -17,273,000 | - | - | - | - | - | - | - |
EBT Margin | -0.8% | -60.78 | -60.30 | -72.90 | -83.58 | -40.99 | -29.93 | -34.02 | -43.96 | -73.10 | - | - | - | - | - |
Net Income | 15.1% | -10,137,000 | -11,933,000 | -9,801,000 | -9,197,000 | -18,039,000 | -13,996,000 | -17,273,000 | -15,416,000 | -14,282,000 | -12,896,000 | -11,333,000 | -11,872,000 | -11,746,000 | -11,359,000 |
Net Income Margin | -0.8% | -60.78 | -60.30 | -72.90 | -83.58 | -41.68 | -28.66 | -33.29 | -43.96 | -90.90 | - | - | - | - | - |
Free Cashflow | -43.7% | -9,805,000 | -6,825,000 | -6,609,000 | -8,006,000 | -10,694,000 | -12,841,000 | -15,873,000 | -12,828,000 | -13,507,000 | - | - | - | - | - |
Balance Sheet | ||||||||||||||||||||||
Description | (%) Q/Q | 2024Q1 | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 |
Assets | -16.9% | 49.00 | 59.00 | 66.00 | 75.00 | 70.00 | 78.00 | 88.00 | 41.00 | 40.00 | 54.00 | 67.00 | 80.00 | 81.00 | 41.00 | 50.00 | 58.00 | 32.00 | 42.00 | 49.00 | 57.00 | 63.00 |
Current Assets | -20.9% | 36.00 | 45.00 | 52.00 | 60.00 | 55.00 | 62.00 | 71.00 | 24.00 | 22.00 | 37.00 | 49.00 | 62.00 | 62.00 | 22.00 | 30.00 | 39.00 | 16.00 | 26.00 | 36.00 | 45.00 | 53.00 |
Cash Equivalents | -21.4% | 35.00 | 44.00 | 50.00 | 59.00 | 54.00 | 61.00 | 69.00 | 15.00 | 13.00 | 29.00 | 42.00 | 47.00 | 60.00 | 12.00 | 7.00 | 38.00 | 8.00 | 7.00 | 10.00 | 11.00 | 9.00 |
Inventory | - | - | - | - | - | - | - | 1.00 | 8.00 | 7.00 | 6.00 | 4.00 | 3.00 | 1.00 | - | - | - | - | - | - | - | - |
Net PPE | -8.4% | 1.00 | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 | 3.00 | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 | 3.00 | 3.00 | 3.00 | 3.00 | 2.00 | 2.00 | 2.00 |
Goodwill | 0% | 3.00 | 3.00 | 3.00 | 3.00 | 3.00 | 3.00 | 3.00 | 3.00 | 3.00 | 3.00 | 3.00 | 3.00 | 3.00 | 3.00 | 3.00 | 3.00 | 3.00 | 3.00 | 3.00 | 3.00 | 3.00 |
Liabilities | -13.0% | 13.00 | 15.00 | 14.00 | 14.00 | 81.00 | 80.00 | 81.00 | 17.00 | 19.00 | 19.00 | 20.00 | 20.00 | 60.00 | 18.00 | 17.00 | 16.00 | 10.00 | 11.00 | 8.00 | 7.00 | 4.00 |
Current Liabilities | -24.3% | 5.00 | 7.00 | 5.00 | 6.00 | 7.00 | 6.00 | 7.00 | 8.00 | 9.00 | 9.00 | 10.00 | 10.00 | 9.00 | 8.00 | 6.00 | 5.00 | 3.00 | 4.00 | 4.00 | 3.00 | 3.00 |
Shareholder's Equity | -18.2% | 36.00 | 44.00 | 52.00 | 61.00 | -10.67 | -2.25 | 6.00 | 23.00 | 21.00 | 36.00 | 47.00 | 60.00 | 20.00 | 23.00 | 33.00 | 42.00 | 22.00 | 31.00 | 41.00 | 50.00 | 59.00 |
Retained Earnings | -3.0% | -347 | -336 | -324 | -314 | -304 | -294 | -285 | -267 | -253 | -236 | -220 | -206 | -191 | -172 | -158 | -145 | -134 | -122 | -108 | -97.15 | -85.80 |
Additional Paid-In Capital | 0.5% | 383 | 381 | 377 | 375 | 294 | 292 | 292 | 291 | 274 | 272 | 268 | 266 | 212 | 195 | 191 | 188 | 156 | 153 | 150 | 147 | 145 |
Shares Outstanding | 0.1% | 55.00 | 55.00 | 55.00 | 55.00 | 38.00 | 37.00 | 37.00 | 31.00 | 30.00 | 30.00 | 30.00 | 26.00 | 26.00 | - | - | - | - | - | - | - | - |
Float | - | - | - | - | 124 | - | - | - | 24.00 | - | - | - | 179 | - | - | - | 135 | - | - | - | 154 | - |
Cashflow (Quarterly) | ||||||||||||||||||||||
Description | (%) Q/Q | 2024Q1 | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 |
Cashflow From Operations | -44.5% | -9,800 | -6,782 | -10,487 | -9,202 | -6,570 | -7,965 | -10,632 | -12,822 | -15,594 | -12,694 | -13,350 | -16,366 | -11,687 | -9,255 | -8,549 | -7,939 | -9,622 | -9,196 | -7,965 | -9,694 | -7,330 |
Share Based Compensation | -47.4% | 1,759 | 3,344 | 1,798 | 1,143 | 896 | 748 | 723 | 1,713 | 2,007 | 3,611 | 1,577 | 2,448 | 6,965 | 2,389 | 2,648 | 2,412 | 2,626 | 3,548 | 2,679 | 2,699 | 2,361 |
Cashflow From Investing | 88.4% | -5.00 | -43.00 | -23.00 | -16.00 | -39.00 | -41.00 | -62.00 | -19.00 | -279 | -134 | -157 | -95.00 | 7,949 | 14,212 | -22,572 | 8,081 | 10,323 | 6,525 | 6,554 | 12,551 | -35,731 |
Cashflow From Financing | -62.1% | 305 | 804 | 2,149 | 13,867 | -432 | -17.00 | 65,058 | 14,963 | -65.00 | -549 | 8,072 | 4,004 | 51,158 | 436 | 426 | 29,759 | 264 | - | 201 | -613 | 494 |
Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited) - USD ($) shares in Thousands, $ in Thousands | 3 Months Ended | |
---|---|---|
Mar. 31, 2024 | Mar. 31, 2023 | |
Revenues: | ||
Total revenues | $ 0 | $ 0 |
Cost and expenses: | ||
Research and development | 6,741 | 5,829 |
General and administrative | 3,874 | 3,733 |
Total cost and expenses | 10,615 | 9,562 |
Loss from operations | (10,615) | (9,562) |
Other income (expense): | ||
Interest income (expense), net | 478 | (239) |
Total other income (expense) | 478 | (239) |
Loss from operations, before income taxes | (10,137) | (9,801) |
Income tax benefit | 0 | 0 |
Net loss | (10,137) | (9,801) |
Comprehensive loss | $ (10,137) | $ (9,801) |
Net loss per share: | ||
Basic and diluted net loss per share (in dollars per share) | $ (0.18) | $ (0.26) |
Weighted average shares used to compute net loss per common share — basic and diluted (in shares) | 55,172 | 37,390 |
Condensed Consolidated Balance Sheets (Current Period Unaudited) - USD ($) $ in Thousands | Mar. 31, 2024 | Dec. 31, 2023 |
---|---|---|
Current assets: | ||
Cash and cash equivalents | $ 34,885 | $ 44,365 |
Prepaid expenses and other current assets | 964 | 963 |
Total current assets | 35,849 | 45,328 |
Property and equipment, net | 1,400 | 1,528 |
Intangible assets, net | 1,719 | 1,886 |
Goodwill | 2,791 | 2,791 |
Right-of-use assets | 7,040 | 7,256 |
Other assets | 365 | 365 |
Total assets | 49,164 | 59,154 |
Current liabilities: | ||
Accounts payable | 1,712 | 1,836 |
Accrued expenses | 2,268 | 3,814 |
Lease liability, current | 1,101 | 1,058 |
Total current liabilities | 5,081 | 6,708 |
Lease liability, less current portion | 7,796 | 8,086 |
Total liabilities | 12,877 | 14,794 |
Commitments and contingencies (Note 8) | ||
Stockholders’ equity: | ||
Preferred stock, $0.001 par value; authorized – 50,000 shares; no shares issued and outstanding | 0 | 0 |
Common stock, $0.001 par value; authorized – 500,000 shares; issued and outstanding – 55,225 shares and 55,144 shares at March 31, 2024 and December 31, 2023 respectively | 55 | 55 |
Additional paid-in capital | 383,284 | 381,220 |
Accumulated other comprehensive income (loss) | 0 | 0 |
Accumulated deficit | (347,052) | (336,915) |
Total stockholders’ equity | 36,287 | 44,360 |
Total liabilities and stockholders’ equity | $ 49,164 | $ 59,154 |